138 related articles for article (PubMed ID: 33608793)
1. Pulse dose steroid experience among hospitalized patients with systemic lupus erythematosus: a single-center feasibility study.
Chaichian Y; Weisman MH; Simard JF
Clin Rheumatol; 2021 Apr; 40(4):1317-1320. PubMed ID: 33608793
[TBL] [Abstract][Full Text] [Related]
2. Developing Electronic Health Record Algorithms That Accurately Identify Patients With Systemic Lupus Erythematosus.
Barnado A; Casey C; Carroll RJ; Wheless L; Denny JC; Crofford LJ
Arthritis Care Res (Hoboken); 2017 May; 69(5):687-693. PubMed ID: 27390187
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus.
Kapoor T; Mahadeshwar P; Hui-Yuen J; Quinnies K; Tatonetti N; Gartshteyn Y; Guo C; Geraldino-Pardilla L; Askanase AD
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32513809
[TBL] [Abstract][Full Text] [Related]
4. Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations.
Jorge AM; Smith D; Wu Z; Chowdhury T; Costenbader K; Zhang Y; Choi HK; Feldman CH; Zhao Y
Lupus; 2022 Oct; 31(11):1296-1305. PubMed ID: 35835534
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal trends of systemic lupus erythematous hospitalizations in the United States: a two-decade population-based study.
Edigin E; Trang A; Ojemolon PE; Eseaton PO; Shaka H; Kichloo A; Bazuaye EM; Okobia NO; Okobia RI; Sandhu V; Manadan A
Clin Rheumatol; 2023 Mar; 42(3):695-701. PubMed ID: 36287285
[TBL] [Abstract][Full Text] [Related]
6. Determining risk factors that increase hospitalizations in patients with systemic lupus erythematosus.
Li D; Madhoun HM; Roberts WN; Jarjour W
Lupus; 2018 Jul; 27(8):1321-1328. PubMed ID: 29667857
[TBL] [Abstract][Full Text] [Related]
7. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
8. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
[TBL] [Abstract][Full Text] [Related]
9. Developing and Validating Methods to Assemble Systemic Lupus Erythematosus Births in the Electronic Health Record.
Barnado A; Eudy AM; Blaske A; Wheless L; Kirchoff K; Oates JC; Clowse MEB
Arthritis Care Res (Hoboken); 2022 May; 74(5):849-857. PubMed ID: 33253488
[TBL] [Abstract][Full Text] [Related]
10. Severe lupus flare is associated with a much higher risk of stroke among patients with SLE.
Chang KC; Lin CH; Chen PL; Wu YH; Hou CW; Huang JA
Int J Stroke; 2023 Oct; 18(8):957-964. PubMed ID: 37089085
[TBL] [Abstract][Full Text] [Related]
11. Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012.
Piga M; Casula L; Perra D; Sanna S; Floris A; Antonelli A; Cauli A; Mathieu A
Lupus; 2016 Jan; 25(1):28-37. PubMed ID: 26199283
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data.
Moores KG; Sathe NA
Vaccine; 2013 Dec; 31 Suppl 10():K62-73. PubMed ID: 24331075
[TBL] [Abstract][Full Text] [Related]
13. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
14. All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database.
Dhital R; Pandey RK; Poudel DR; Oladunjoye O; Paudel P; Karmacharya P
Rheumatol Int; 2020 Mar; 40(3):393-397. PubMed ID: 31773392
[TBL] [Abstract][Full Text] [Related]
15. Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosus.
O'Malley T; Xie F; Su Y; Clinton C; Zack DJ; Haechung C; Grabner M; Curtis JR
J Manag Care Spec Pharm; 2022 Sep; 28(9):1021-1032. PubMed ID: 35775579
[No Abstract] [Full Text] [Related]
16. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
Ward MM
J Rheumatol; 2002 Jun; 29(6):1198-206. PubMed ID: 12064835
[TBL] [Abstract][Full Text] [Related]
17. Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
Gu K; Gladman DD; Su J; Urowitz MB
J Rheumatol; 2017 Aug; 44(8):1173-1178. PubMed ID: 28620060
[TBL] [Abstract][Full Text] [Related]
18. Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000-2019.
Mendoza-Pinto C; Etchegaray-Morales I; Munguía-Realpozo P; Solis-Poblano JC; Méndez-Martínez S; Osorio-Peña ÁD; Ayón-Aguilar J; Abud-Mendoza C; García-Carrasco M
Lupus; 2022 Nov; 31(13):1679-1684. PubMed ID: 36128770
[TBL] [Abstract][Full Text] [Related]
19. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
20. Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.
Mathias SD; Berry P; De Vries J; Askanase A; Pascoe K; Colwell HH; Chang DJ
Health Qual Life Outcomes; 2017 Feb; 15(1):43. PubMed ID: 28245854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
